Page 1 | Search Results | Blood | American Society of Hematology

1-6 of 6

Sort by

Sort Order Select

Journal Articles

A Clinical Trial of Cannabis As Targeted Therapy for Indolent Leukemic Lymphoma

Christopher M Melén, MD, Magali Merrien, MSc, Agata Wasik, MSc, PhD, Kristina Sonnevi, MD PhD, Henna-Riikka Junlén, MD, Birger Christersson, MD PhD, Birgitta Sander, MD PhD Prof., Björn E Wahlin, MD PhD

Blood (2019) 134 (Supplement_1): 5487.

https://doi.org/10.1182/blood-2019-126693

Published: 2019

Journal Articles

A Case Report of the Benefit of Cannabidiol (Cannabidiol (CBD)-Predominant Medical Cannabis Preparation) in the Management of Refractory Skin Graft Vs Host Disease (GVHD)

Tsiporah B. Shore, MD, Jessy B. Ryan, ANP, Michael B. Samuel, MD

Blood (2019) 134 (Supplement_1): 5687.

https://doi.org/10.1182/blood-2019-122715

Published: 2019

Journal Articles

Cannabidiol Reduces Acute and Chronic Hyperalgesia in Humanized Sickle Mice

Varun Sagi, BS, Jianxun Lei, PhD, Stacy B Kiven, BS, Huy Tran, BS, Kalpna Gupta, PhD

Blood (2019) 134 (Supplement_1): 77.

https://doi.org/10.1182/blood-2019-129706

Published: 2019

Journal Articles

Synergistic Effect of Cannabidiol with Conventional Chemotherapy Treatment

Tori Strong, PhD, Jana Rauvolfova, PhD, Elias Jackson, PhD, Lan V. Pham, PhD, Jerry Bryant

Blood (2018) 132 (Supplement 1): 5382.

https://doi.org/10.1182/blood-2018-99-116749

Published: 2018

Journal Articles

Cannabidiol - An Innovative Strategy For Graft Versus Host Disease Prevention

Moshe Yeshurun, MD, Ofer Shpilberg, MD, MPH, Corina Herscovici, MD, Juliet Dreyer, RN, Anat Peck, RN, Maly Levy Assaraf, PhD, Tsipora Gruenewald, M.Ph.Sc, Raphael Mechoulam, PhD, Ron Ram, MD

Blood (2013) 122 (21): 3299.

https://doi.org/10.1182/blood.V122.21.3299.3299

Published: 2013

Journal Articles

Cannabinoid Receptor 1 in Chronic Lymphocytic Leukemia: Strong Prognostic Marker with Limited Therapeutic Use

Patricia Weiss, Edit Anna Porpaczy, MD, Trang Le, Cathrin Skrabs, Michaela Gruber, Clemens Pausz, Ulrich Jäger, Katrina Vanura

Blood (2012) 120 (21): 4565.

https://doi.org/10.1182/blood.V120.21.4565.4565

Published: 2012

NARROW

A Clinical Trial of Cannabis As Targeted Therapy for Indolent Leukemic Lymphoma

A Case Report of the Benefit of Cannabidiol (Cannabidiol (CBD)-Predominant Medical Cannabis Preparation) in the Management of Refractory Skin Graft Vs Host Disease (GVHD)

Cannabidiol Reduces Acute and Chronic Hyperalgesia in Humanized Sickle Mice

Synergistic Effect of Cannabidiol with Conventional Chemotherapy Treatment

Cannabidiol - An Innovative Strategy For Graft Versus Host Disease Prevention

Cannabinoid Receptor 1 in Chronic Lymphocytic Leukemia: Strong Prognostic Marker with Limited Therapeutic Use

Email alerts

ASH Publications

American Society of Hematology

A Clinical Trial of Cannabis As Targeted Therapy for Indolent Leukemic Lymphoma

A Case Report of the Benefit of Cannabidiol (Cannabidiol (CBD)-Predominant Medical Cannabis Preparation) in the Management of Refractory Skin Graft Vs Host Disease (GVHD)

Cannabidiol Reduces Acute and Chronic Hyperalgesia in Humanized Sickle Mice

Synergistic Effect of Cannabidiol with Conventional Chemotherapy Treatment

Cannabidiol - An Innovative Strategy For Graft Versus Host Disease Prevention

Cannabinoid Receptor 1 in Chronic Lymphocytic Leukemia: Strong Prognostic Marker with Limited Therapeutic Use

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only